Titan Pharmaceuticals Inc. (NASDAQ: TTNP)
$4.76
+0.0900 ( +1.93% ) 0.6K
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Market Data
Open
$4.76
Previous close
$4.67
Volume
0.6K
Market cap
$4.13M
Day range
$4.51 - $5.29
52 week range
$4.24 - $13.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Jan 18, 2024 |
8-k | 8K-related | 13 | Jan 08, 2024 |
8-k | 8K-related | 14 | Dec 28, 2023 |
def | Proxies and info statements | 1 | Nov 28, 2023 |
pre | Proxies and info statements | 1 | Nov 17, 2023 |
8-k | 8K-related | 12 | Nov 15, 2023 |
10-q | Quarterly Reports | 53 | Nov 14, 2023 |
4 | Insider transactions | 1 | Oct 26, 2023 |
4 | Insider transactions | 1 | Oct 26, 2023 |
4 | Insider transactions | 1 | Oct 26, 2023 |